General Information of the Compound
| Compound ID |
CP0073285
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-[4-[4-(2-hydroxyphenyl)piperazin-1-yl]butyl]-2,4-dimethyl-7-phenylpurino[7,8-a]imidazole-1,3-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H33N7O3
|
||||||||||||||||||
| Molecular Weight |
527.629
|
||||||||||||||||||
| Canonical SMILES |
Cn1c2nc3n(CCCCN4CCN(CC4)c4ccccc4O)c(cn3c2c(=O)n(C)c1=O)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H33N7O3/c1-31-26-25(27(38)32(2)29(31)39)36-20-23(21-10-4-3-5-11-21)35(28(36)30-26)15-9-8-14-33-16-18-34(19-17-33)22-12-6-7-13-24(22)37/h3-7,10-13,20,37H,8-9,14-19H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
VPBKGYIOHOLSGS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor